The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 12, 2018

Filed:

Mar. 30, 2015
Applicants:

Universite DE Liege, Angleur, BE;

Paul Maes, Vise, BE;

Inventors:

Didier Cataldo, Olne, BE;

Brigitte Evrard, Embourg, BE;

Gilles Dufour, Wanze, BE;

Pascal de Tullio, Jupille-sur-Meuse, BE;

Paul Maes, Vise, BE;

Assignee:

Other;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/58 (2006.01); A61K 31/56 (2006.01); A61K 31/573 (2006.01); C08B 37/16 (2006.01); C08L 5/16 (2006.01); A61K 9/00 (2006.01); A61K 31/57 (2006.01); A61K 47/40 (2006.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 31/58 (2013.01); A61K 9/0073 (2013.01); A61K 31/56 (2013.01); A61K 31/57 (2013.01); A61K 31/573 (2013.01); A61K 47/40 (2013.01); A61K 47/6951 (2017.08); C08B 37/0015 (2013.01); C08L 5/16 (2013.01);
Abstract

The present invention relates to novel and useful pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and/or prevention of pulmonary inflammatory disease. The present invention also relates to a novel and useful analytical technique for the detection and the quantification of HP-β-CD in solution. More specifically, the present invention relates to the use of a validated 1H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without any extraction or separation steps for liquid formulations.


Find Patent Forward Citations

Loading…